miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells
- PMID: 25128483
- PMCID: PMC4158130
- DOI: 10.1186/1476-4598-13-193
miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells
Abstract
Background: MicroRNAs (miRNAs) have been identified as important posttranscriptional regulators involved in various biological and pathological processes of cells, but their association with tumor chemoresistance has not been fully understood.
Methods: We detected miR-27a expression in two lung adenocarcinoma cell lines, A549 and A549/CDDP, and then investigated the effects of miR-27a on the metastasis and the chemosensitivity of cancer cells, using both gain- and loss-of-function studies. The correlation between miR-27a level and chemoresistance was further investigated in clinical lung adenocarcinoma specimens.
Results: miR-27a was significantly up-regulated in cisplatin-resistant lung adenocarcinoma A549/CDDP cells compared with parental A549 cells. miR-27a regulates epithelial-mesenchymal transition (EMT) and cisplatin resistance in vitro and modulates response of lung adenocarcinoma cells to cisplatin in vivo. Further studies identified Raf Kinase Inhibitory Protein (RKIP) as a direct and functional target of miR-27a. Small interfering RNA-mediated RKIP knockdown revealed similar effects as that of ectopic miR-27a expression, while overexpression of RKIP attenuated the function of miR-27a in lung adenocarcinoma cells. Increased miR-27a expression was also detected in tumor tissues sampled from lung adenocarcinoma patients treated with cisplatin-based chemotherapy and was proved to be correlated with low expression of RKIP, decreased sensitivity to cisplatin, and poor prognosis.
Conclusion: Our results suggest that up-regulation of miR-27a could suppress RKIP expression and in turn contribute to chemoresistance of lung adenocarcinoma cells to cisplatin.
Figures






Similar articles
-
miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.Cancer Gene Ther. 2015 Apr;22(3):108-14. doi: 10.1038/cgt.2014.73. Epub 2015 Feb 27. Cancer Gene Ther. 2015. PMID: 25721211
-
Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.Mol Cancer. 2020 Jun 24;19(1):109. doi: 10.1186/s12943-020-01229-y. Mol Cancer. 2020. PMID: 32580736 Free PMC article.
-
miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.Oncotarget. 2016 Apr 26;7(17):24510-26. doi: 10.18632/oncotarget.8229. Oncotarget. 2016. PMID: 27014910 Free PMC article.
-
The increase of miR-27a affects the role of cisplatin on proliferation and migration capacities of liver cancer cells.Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5490-5498. doi: 10.26355/eurrev_201809_15809. Eur Rev Med Pharmacol Sci. 2018. PMID: 30229820
-
Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators.Cell Signal. 2021 Feb;78:109871. doi: 10.1016/j.cellsig.2020.109871. Epub 2020 Dec 3. Cell Signal. 2021. PMID: 33279671 Review.
Cited by
-
MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells.Onco Targets Ther. 2020 Jul 14;13:6873-6884. doi: 10.2147/OTT.S256153. eCollection 2020. Onco Targets Ther. 2020. PMID: 32764979 Free PMC article.
-
Association between pre-miR-27a functional polymorphism and risk of colorectal cancer in north Chinese Han population.Onco Targets Ther. 2015 Oct 19;8:3003-7. doi: 10.2147/OTT.S89754. eCollection 2015. Onco Targets Ther. 2015. PMID: 26527885 Free PMC article.
-
MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1.Oncotarget. 2016 May 3;7(18):25276-90. doi: 10.18632/oncotarget.8252. Oncotarget. 2016. PMID: 27013583 Free PMC article.
-
miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.Tumour Biol. 2016 Oct;37(10):13287-13294. doi: 10.1007/s13277-016-5244-2. Epub 2016 Jul 26. Tumour Biol. 2016. PMID: 27460077
-
Identification of Integrin β1 as a Novel PAG1-Interacting Protein Involved in the Inherent Radioresistance of Human Laryngeal Carcinoma.J Cancer. 2018 Oct 18;9(22):4128-4138. doi: 10.7150/jca.26885. eCollection 2018. J Cancer. 2018. PMID: 30519312 Free PMC article.
References
-
- Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK. Annual report to the nation on the status of cancer, 1975–2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100:1672–1694. doi: 10.1093/jnci/djn389. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous